PDCD1 and colorectal carcinoma: Colorectal Cancer (CRC): CT26 (BALB/c) and MC38 (C57BL/6) syngeneic models, modeling MSI-high and “hot” CRC phenotypes, respectively, and routinely used to assess PD-1/PD-L1 blockade efficacy (29, 30).